# FDA Inspection 1200979 - CSL Plasma Inc. - February 17, 2023

Source: https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/12175cb2-1ba3-4b9c-89ea-d64d0e1d753f
Source feed: FDA_Inspections

> FDA Inspection 1200979 for CSL Plasma Inc. on February 17, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1200979
- Company Name: CSL Plasma Inc.
- Inspection Date: 2023-02-17
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1200979 - 2023-02-17](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/506a5e65-009f-4971-b3b6-e80952850574)
- [FDA Inspection 1037339 - 2018-01-10](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/344ad77d-5cbd-4c02-b9ca-8fa5beb0f3ad)
- [FDA Inspection 958347 - 2016-02-01](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/5d94706b-ba27-42e0-866a-bb2e46c9004b)

Company: https://www.keypedia.com/companies/csl-plasma-inc/5e968fb4-e621-46a6-aa3e-5e4ea1ea4ff0

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d